Dear all,
We are delighted to announce that Dr. Hong Wang, Senior Manager at U.S. Pharmacopeia (USP) will join us again on Apr 25th 12-1pm US EDT to give a talk on the Excipient Nomenclature Guidelines released to public in 2023. Please check out the abstract. We look forward to seeing you all in April again!
Presentation Title: Excipient Nomenclature Guidelines
Abstract:
This presentation will introduce the USP Excipient Nomenclature Guidelines released to the public in March 2023 and is the first USP nomenclature guidelines for excipients. Topics covered include the guideline’ outlines, excipient classifications, the definition of excipient component, and will further focus on two specific areas, nomenclatures for lipids and polymers which are multiple component-based excipients. With applications of more advanced analytical techniques for lipids and polymers, appropriate naming can be assigned in the USP/NF. Additionally, this discussion will delve into how the guidelines help align the names in USP/NF standards, FDA inactive ingredient database, and the FDA global substance registration system; address FDA’s Q1 sameness requirements for complex generics to indicate excipient types in meeting the needs of complex generics and innovative therapeutics; and to guide stakeholders to understand excipient composition and profiles.
Best regards,
Jiaying on behalf of AAPS Excipient Community LT
Microsoft Teams meeting
Join on your computer, mobile app or room device
Click here to join the meeting
Meeting ID: 234 576 468 255
Passcode: 9dxy8S
Download Teams | Join on the web
Join with a video conferencing device
[email protected]
Video Conference ID: 118 944 342 0
Alternate VTC instructions
Or call in (audio only)
+1 856-295-2448,,548070575# United States, Camden
Phone Conference ID: 548 070 575#
Find a local number | Reset PIN
Data, including recorded meetings, with content, subject to legal hold must be preserved. By joining this session, you consent to the terms and conditions outlined in the “Legal” link below.
Learn More | Help | Meeting options | Legal